市場調査レポート

商品コード

放射性医薬品の世界市場 2025～2029年

Global Radiopharmaceuticals Market 2025-2029

出版日: 2025年02月08日
発行: TechNavio
ページ情報: 英文 214 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 358,925円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 574,280円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

放射性医薬品市場は、2024～2029年にかけて70億2,050万米ドル、予測期間中のCAGRは12.3%で成長すると予測されています。

当レポートでは、放射性医薬品市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、神経疾患の罹患率の上昇、がん患者の増加と腫瘍学市場への投資の増加、放射性医薬品の副作用の最小化などが牽引しています。

市場範囲
基準年	2025年
終了年	2029年
予測期間	2025～2029年
成長モメンタム	加速
前年比[2025年]	10.7%
CAGR	12.3%
増分額	70億2,050万米ドル

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには履歴データと予測データがあります。

本調査では、サイクロトロンベースの放射性医薬品の生産が、今後数年間の放射性医薬品市場の成長を促進する主要な理由の一つであると特定しています。また、新しい放射性医薬品の発見と開発、新興経済諸国における医療インフラの改善は、市場の大きな需要につながると考えられます。

地域別セグメンテーション
比較：地域別
北米：市場規模と予測 2024～2029年
欧州：市場規模と予測 2024～2029年
アジア：市場規模と予測 2024～2029年
その他：市場規模と予測 2024～2029年
米国：市場規模と予測 2024～2029年
ドイツ：市場規模と予測 2024～2029年
英国：市場規模と予測 2024～2029年
カナダ：市場規模と予測 2024～2029年
中国：市場規模と予測 2024～2029年
日本：市場規模と予測 2024～2029年
フランス：市場規模と予測 2024～2029年
ブラジル：市場規模と予測 2024～2029年
インド：市場規模と予測 2024～2029年
アラブ首長国連邦：市場規模と予測 2024～2029年
地域情勢による市場機会

第13章促進要因・課題・機会・抑制要因

市場促進要因
市場課題
促進要因と課題の影響
市場機会・抑制要因

第14章競合情勢

概要
競合情勢
混乱の状況
産業のリスク

第15章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
Bayer AG
Bracco Spa
Cardinal Health Inc.
Curium Pharma
Eckert and Ziegler AG
GE Healthcare Technologies Inc.
IBA Radiopharma Solutions
Jubilant Draximage Radiopharmacies Inc.
Lantheus
NorthStar Medical Radioisotopes LLC
Novartis AG
NTP Radioisotopes SOC Ltd.
PharmaLogic Holdings Corp.
Siemens AG
Sotera Health Co.

第16章付録

Product Code: IRTNTR43963

The radiopharmaceuticals market is forecasted to grow by USD 7020.5 million during 2024-2029, accelerating at a CAGR of 12.3% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of neurological disorders, growing cancer cases and rising investment in oncology market, and minimal side effects of radiopharmaceuticals.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	10.7%
CAGR	12.3%
Incremental Value	$7020.5 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's radiopharmaceuticals market is segmented as below:

By Source

Cyclotrons
Nuclear reactors

By End-user

Diagnostics
Therapeutics

By Application

Oncology
Cardiology
Neurology

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

Radiopharmaceuticals Market sizing
Radiopharmaceuticals Market forecast
Radiopharmaceuticals Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Draximage Radiopharmacies Inc., Lantheus, Mallinckrodt PLC, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd.. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Radiopharmaceuticals Market 2019 - 2023
- Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2019 - 2023 ($ million)
5.2 Source segment analysis 2019 - 2023
- Historic Market Size - Source Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 AI Impact on Global Radiopharmaceuticals Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Source

8.1 Market segments
- Chart on Source - Market share 2024-2029 (%)
- Data Table on Source - Market share 2024-2029 (%)
8.2 Comparison by Source
- Chart on Comparison by Source
- Data Table on Comparison by Source
8.3 Cyclotrons - Market size and forecast 2024-2029
- Chart on Cyclotrons - Market size and forecast 2024-2029 ($ million)
- Data Table on Cyclotrons - Market size and forecast 2024-2029 ($ million)
- Chart on Cyclotrons - Year-over-year growth 2024-2029 (%)
- Data Table on Cyclotrons - Year-over-year growth 2024-2029 (%)
8.4 Nuclear reactors - Market size and forecast 2024-2029
- Chart on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
- Data Table on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
- Chart on Nuclear reactors - Year-over-year growth 2024-2029 (%)
- Data Table on Nuclear reactors - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Source
- Market opportunity by Source ($ million)
- Data Table on Market opportunity by Source ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Diagnostics - Market size and forecast 2024-2029
- Chart on Diagnostics - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostics - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
9.4 Therapeutics - Market size and forecast 2024-2029
- Chart on Therapeutics - Market size and forecast 2024-2029 ($ million)
- Data Table on Therapeutics - Market size and forecast 2024-2029 ($ million)
- Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Application

10.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
10.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Cardiology - Market size and forecast 2024-2029
- Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiology - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
10.5 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.5 Bracco Spa
- Bracco Spa - Overview
- Bracco Spa - Product / Service
- Bracco Spa - Key offerings
- SWOT
15.6 Cardinal Health Inc.
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
- SWOT
15.7 Curium Pharma
- Curium Pharma - Overview
- Curium Pharma - Product / Service
- Curium Pharma - Key offerings
- SWOT
15.8 Eckert and Ziegler AG
- Eckert and Ziegler AG - Overview
- Eckert and Ziegler AG - Business segments
- Eckert and Ziegler AG - Key news
- Eckert and Ziegler AG - Key offerings
- Eckert and Ziegler AG - Segment focus
- SWOT
15.9 GE Healthcare Technologies Inc.
- GE Healthcare Technologies Inc. - Overview
- GE Healthcare Technologies Inc. - Business segments
- GE Healthcare Technologies Inc. - Key news
- GE Healthcare Technologies Inc. - Key offerings
- GE Healthcare Technologies Inc. - Segment focus
- SWOT
15.10 IBA Radiopharma Solutions
- IBA Radiopharma Solutions - Overview
- IBA Radiopharma Solutions - Business segments
- IBA Radiopharma Solutions - Key news
- IBA Radiopharma Solutions - Key offerings
- IBA Radiopharma Solutions - Segment focus
- SWOT
15.11 Jubilant Draximage Radiopharmacies Inc.
- Jubilant Draximage Radiopharmacies Inc. - Overview
- Jubilant Draximage Radiopharmacies Inc. - Product / Service
- Jubilant Draximage Radiopharmacies Inc. - Key offerings
- SWOT
15.12 Lantheus
- Lantheus - Overview
- Lantheus - Business segments
- Lantheus - Key offerings
- Lantheus - Segment focus
- SWOT
15.13 NorthStar Medical Radioisotopes LLC
- NorthStar Medical Radioisotopes LLC - Overview
- NorthStar Medical Radioisotopes LLC - Product / Service
- NorthStar Medical Radioisotopes LLC - Key offerings
- SWOT
15.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.15 NTP Radioisotopes SOC Ltd.
- NTP Radioisotopes SOC Ltd. - Overview
- NTP Radioisotopes SOC Ltd. - Product / Service
- NTP Radioisotopes SOC Ltd. - Key offerings
- SWOT
15.16 PharmaLogic Holdings Corp.
- PharmaLogic Holdings Corp. - Overview
- PharmaLogic Holdings Corp. - Product / Service
- PharmaLogic Holdings Corp. - Key offerings
- SWOT
15.17 Siemens AG
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key news
- Siemens AG - Key offerings
- Siemens AG - Segment focus
- SWOT
15.18 Sotera Health Co.
- Sotera Health Co. - Overview
- Sotera Health Co. - Business segments
- Sotera Health Co. - Key news
- Sotera Health Co. - Key offerings
- Sotera Health Co. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

放射性医薬品の世界市場 2025～2029年

Global Radiopharmaceuticals Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：供給源別

第9章市場セグメンテーション：エンドユーザー別

第10章市場セグメンテーション：用途別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Source

9 Market Segmentation by End-user

10 Market Segmentation by Application

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

放射性医薬品の世界市場 2025～2029年

Global Radiopharmaceuticals Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：供給源別

第9章 市場セグメンテーション：エンドユーザー別

第10章 市場セグメンテーション：用途別

第11章 顧客情勢

第12章 地域別情勢

第13章 促進要因・課題・機会・抑制要因

第14章 競合情勢

第15章 競合分析

第16章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Source

9 Market Segmentation by End-user

10 Market Segmentation by Application

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：供給源別

第9章市場セグメンテーション：エンドユーザー別

第10章市場セグメンテーション：用途別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録